Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort Studies

By afschroeder • April 4, 2026

Cescon E, Goodwin P, Bobrie A, Thezenas S, Ganz T, Nemeth E, Lohmann A, Ennis M, Jacot W, Jerzak KJ. Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort Studies. Clin Breast Cancer. 2026 Apr 2;26(5):29-35. doi: 10.1016/j.clbc.2026.03.004. Epub ahead of print. PMID: 41932199.

Tags: biomarkers, breast neoplasms, Inflammation, iron metabolism, Obesity, Publications, Pulmonary, Critical Care & Sleep Medicine

Mucus plugs in chronic obstructive pulmonary disease are heterogeneous in size and shape and occur in relatively large airways

Farooqui ON, Elicker BM, Henry TS, Hahn LD, Kallianos KG, Han MK, Barr RG, Smith BM, Comellas AP, Bon J, Hansel N, Wells JM, Paine[...]

Measures of Vascular Volume in the Lung: An Emerging Quantitative Tool for Clinical and Physiological Studies in Pulmonary Vascular Disease

Rahaghi FN. Measures of Vascular Volume in the Lung: An Emerging Quantitative Tool for Clinical and Physiological Studies in Pulmonary Vascular Disease. Am J Respir[...]

Genomic surveillance of human metapneumovirus in the United States, 2010-2025

Bendall EE, Fitzsimmons WJ, Valvano WD, Truscon R, Self WH, Halasa N, Chappell JD, Zhu Y, Safdar B, Ginde AA, Peltan ID, Gaglani M, Columbus[...]